Public Comment on Draft Research Plan: Screening for Dyslipidemia and Use of Statins to Improve Cardiovascular Outcomes in Adults
Agency for Healthcare Research and Quality (AHRQ) sent this bulletin at 02/27/2014 12:05 PM EST
The U.S. Preventive Services Task Force posted today for public comment a draft Research Plan on screening for dyslipidemia and use of statins to improve cardiovascular outcomes in adults. The draft Research Plan is available for review and public comment from February 27 through March 26, 2014. To review the draft Research Plan and submit comments, go to http://www.uspreventiveservicestaskforce.org/tfcomment.htm.
In an effort to make the U.S. Preventive Services Task Force (USPSTF) recommendations clearer and its processes more transparent, the Task Force started posting draft Recommendation Statements online for public comment in 2010. To further enhance its work, the Task Force began inviting public comment on all its draft Research Plans in December 2011 and its draft Evidence Reports in March 2013.
To learn more about and comment on USPSTF draft Research Plans, Evidence Reports, or Recommendation Statements, continue reading below.
Research Plans
A small group of USPSTF members, called topic leads, works with researchers from the Evidence-based Practice Center (EPC) to create a draft Research Plan to guide the systematic review of the evidence. The Research Plan consists of an analytic framework, key questions, and a literature search strategy or research approach.
Each draft Research Plan is posted for public comment for 4 weeks. The USPSTF topic leads, with the assistance of the EPC researchers, review all of the comments received, revise the draft plan, and develop a final Research Plan. The final Research Plan is then posted on this Web site.
Evidence Reports
The research team at the EPC independently implements the final Research Plan by conducting a systematic review of the evidence to address the questions posed by the USPSTF. The research team presents a draft Evidence Report to the full USPSTF at one of its in-person meetings. After the meeting, each draft Evidence Report is shared with a panel of external subject matter experts and posted for public comment for 4 weeks. Based on feedback received from Task Force members, subject matter experts, and the public, the research team finalizes the Evidence Report and prepares a manuscript summarizing the evidence for publication in a peer-reviewed journal or on this Web site.
The USPSTF, in partnership with AHRQ's Effective Health Care (EHC) Program, also offers opportunities for public comment on EHC draft Evidence Reports that are related to the USPSTF's work. To learn more about and comment on draft Evidence Reports from AHRQ's EHC Program, visit http://effectivehealthcare.ahrq.gov/index.cfm/research-available-for-comment/.
Recommendation Statements
During one of its in-person meetings, the entire USPSTF reviews the evidence, evaluates the benefits and harms of the clinical preventive service, and discusses and develops one or more specific recommendations.
After the meeting, the topic leads write a full draft Recommendation Statement that includes the specific recommendations of the entire USPSTF, a rationale section, a section of clinical considerations to guide health care professionals, and a discussion section that reviews the evidence and discusses the recommendations of other organizations. The USPSTF posts its draft Recommendation Statement on this Web site for public comment for 4 weeks. The USPSTF topic leads review all of the comments received and revise the draft Recommendation Statement. The final Recommendation Statement is reviewed and voted on by the full Task Force, and posted on this Web site.
How to Comment
Any visitor to this site can comment on any of the listed USPSTF draft documents. However, readers should note that the USPSTF writes these documents for researchers, primary care doctors, and other health care providers, using medical and scientific language as appropriate for these audiences.
To comment, click on the type of draft document in the box at top right. Comments must be received before the comment deadline listed below each title. The comment period for draft documents is 4 weeks.
Once the draft Research Plan, Evidence Report, or Recommendation Statement is removed from the public comment page, the USPSTF begins considering comments and finalizing the document. Until the final Recommendation Statement is published, the USPSTF considers the Recommendation Statements on this Web site to be current.
You will receive acknowledgement that your comments have been transmitted. At the present time, the USPSTF cannot provide responses to individual comments.
Previous Opportunities for Public Comment
To view a list of previous opportunities for public comment, select: http://www.uspreventiveservicestaskforce.org/tflistprev.htm.
Current as of February 2014
Internet Citation:
Opportunities for Public Comment. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/tfcomment.htm
Available for Comment
Screening for Dyslipidemia and Use of Statins to Improve Cardiovascular Outcomes in Adults
- Draft Research Plan
February 27–March 26, 2014
Screening for Chronic Obstructive Pulmonary Disease Using Spirometry
- Draft Research Plan
February 20–March 19, 2014
Screening for Carotid Artery Stenosis
- Draft Recommendation Statement
February 18–March 17, 2014 - Draft Evidence Report
February 18–March 17, 2014
Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults
- Draft Recommendation Statement
February 11–March 10, 2014 - Draft Evidence Report
February 11–March 10, 2014
Helpful Information
Tell me more about clinical preventive services.
Tell me more about the U.S. Preventive Services Task Force (USPSTF).
Tell me how the Agency for Healthcare Research and Quality supports the USPSTF.
Tell me more about the USPSTF Recommendation Statements and how they are used.
Tell me why USPSTF Recommendations are addressed to primary care providers instead of individuals.
Tell me who serves on the USPSTF and how they are selected.
Tell me how I can nominate a clinical preventive health service for the USPSTF to consider.
Tell me more about the U.S. Preventive Services Task Force (USPSTF).
Tell me how the Agency for Healthcare Research and Quality supports the USPSTF.
Tell me more about the USPSTF Recommendation Statements and how they are used.
Tell me why USPSTF Recommendations are addressed to primary care providers instead of individuals.
Tell me who serves on the USPSTF and how they are selected.
Tell me how I can nominate a clinical preventive health service for the USPSTF to consider.
No hay comentarios:
Publicar un comentario